StageBio, a leading provider of histology, pathology, image analysis, specimen archiving and biorepository services, is pleased to announce a strategic partnership with Pathcore, an innovative digital and computational pathology solutions provider. This collaboration marks a significant milestone in the advancement of pathology solutions, offering enhanced digital workflows, and improved efficiency for clients worldwide.
StageBio is attending and presenting at the 42nd Annual Society of Toxicologic Pathology (STP) Symposium. This year’s theme, “Toxicologic Pathology of the Hepatobiliary System”, will bring attendees together to discuss new and emerging topics with keynote sessions, poster presentations and more. The 2023 event takes place June 25-28 in Summerlin, Nevada.
StageBio announces the addition of DuraTemp ULT Backup Solution to its biorepository and archiving facility repertoire.
By Dr. Stephanie Shrader, DVM, PhD, DACVP Director, General Toxicologic Pathology
StageBio will host a booth at the 26th American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting. Each year, the ASGCT Annual Meeting brings gene and cell therapy professionals together with the broader life sciences community to discuss exciting developments, share findings from groundbreaking research and exchange thought-provoking ideas. The 2023 event takes place May 16-20 at the Los Angeles Convention Center in Los Angeles, CA.
StageBio, the leading international provider of GLP-compliant research, preclinical and clinical histology, pathology, biorepository and specimen archiving services for the biopharmaceutical, medical device and contract research industries, is an exhibitor at the International Society for Biological and Environmental Repositories (ISBER) 2023 Annual Meeting.
The immune system is extraordinarily complex. It consists of immune cells, tissues, organs, and a whole host of other substances and factors that help the body fight off infection, remove abnormal cells, and maintain overall homeostasis.
The StageBio team is looking forward to exhibiting and attending at the ARVO Annual Meeting & Expo in New Orleans, LA. The ARVO conference will provide attendees access to new research, educational and professional development programming and networking opportunities for anyone working in the area of eye and vision research.
The StageBio team is looking forward to attending the 62nd Annual SOT Annual Meeting & Expo held March 19-23 in Nashville, Tennessee.
StageBio Distinguished Pathologist Dr. Serge Rousselle, DVM, DACVP, recently gave a webinar presentation on the key considerations of accurate evaluation for medical device safety, efficacy, healing, and biocompatibility in nonclinical assessments.
513.204.4400
